申请人:Merck & Co., Inc.
公开号:US05344830A1
公开(公告)日:1994-09-06
Diacylpiperazines of general structure ##STR1## are tachykinin receptor antagonists useful in the treatment of inflammatory diseases, pain or migraine, and asthma, and calcium channel blockers useful in the treatment of cardiovascular conditions such as angina, hypertension or ischemia.
通用结构##STR1##的二酰基哌嗪是治疗炎症性疾病、疼痛或偏头痛以及哮喘的速激肽受体拮抗剂,同时也是治疗心血管疾病如心绞痛、高血压或缺血的钙通道阻滞剂。